Meropenem – AMSOPEN 1g

Amsopen 1 g – Meropenem Powder for IV Injection/Infusion

• Active ingredient: Meropenem trihydrate, equivalent to 1 g anhydrous meropenem per vial sahar.ph+11verification.fda.gov.ph+11myhealthbox.eu+11

• Formulation: White to pale‑yellow sterile powder in a glass vial, with sodium carbonate (~90 mg) as a stabilizer

• Packaging: Each box contains one vial plus two 10 mL sterile diluent ampoules.

Clinical Use & Administration

• Antibacterial spectrum: Broad coverage against Gram-positive, Gram-negative, and anaerobes—ideal for empiric therapy in serious or resistant infections

• Indications: Hospital/ventilator‑associated pneumonia, intra‑abdominal infections, complicated UTIs, bacterial meningitis, skin/soft tissue infections, febrile neutropenia, bacteremia in children ≥3 months and adults

• Dosage: Typically 1 g IV every 8 hours in adults; pediatric and renal‑adjusted dosing also applicable (e.g., 10–40 mg/kg q8h in children, modified for kidney function).

Safety & Precautions

• Common side effects: Diarrhea, nausea, headache, rash, elevated liver enzymes; risk of hypersensitivity reactions

• Serious risks: Rare seizures (especially in renal impairment or CNS issues); monitor for allergic response unilab.com.ph

• Storage & preparation: Store below 25 °C; reconstitute and infuse under sterile conditions; use promptly after reconstitution.